This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharmareps. The most desired information doctors now want is about patient assistance programs, with 49% saying they want pharmareps to provide that information. Where to start? Here are some options.
Will patients be happy with telehealth once they feel it’s safe to return to physicians’ offices? Back to HCP’s…digitization can’t replace the relationships that pharmareps and MLS people build with doctors. What we need to look at is the crop of new physicians who are entering practice.
For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions. Channel Use in Flux.
In conjunction with CMI Media Group’s international expansion beyond the United States, we conducted research and published a report in partnership with Medscape which delved into the media habits of physicians across the EU5 countries: France, Germany, Italy, Spain, and the United Kingdom.
Omnichannel is the latest buzzword-making rounds within pharma, but omnichannel has no relevance if your message is too promotional or is irrelevant to your audience. 68% of HCPs indicate webinars or webcasts as their most preferred channel to receive information. The channel IS essential but not as important as your message.
As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. INSIGHT: This study shows that HCPs are demanding more from pharma, but these data points should not be used across all specialties.
Of the 75% of physicians who preferred in-person visits from Medtech representatives prior to Covid-19, 47% now prefer virtual exchanges or less-frequent visits. Furthermore, only 10% of physicians had met with a pharmaceutical company representative in a hospital. and the U.S., and the U.S.,
SUMMARY: Today, more physicians and patients rely on the Internet to answer their questions about emerging treatments, including prescription drugs. If there is one industry that needs to think more about digital, it’s pharma. This is a severe concern in an era where more HCPs are refusing to meet with pharmareps.
Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?
As pharmareps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.
A decade ago, pharmareps could easily book in-person meetings with doctors, build lasting relationships, and crush their sales quotas. Physicians are harder to get hold of in 2023. We have yet to talk about the increased level of competition that modern reps have to deal with. Pharmaceutical sales have changed.
Developed to address ongoing provider burnout head-on, the new practice engagement solution reimagines how clinical care teams communicate and collaborate by providing a centralized hub for physicians and staff. PatientPoint plans to release the solution to other specialties within its network in 2025.For Learn more at patientpoint.com.
That’s a lot of information. Periodic observation, coaching sessions, client feedback, and role-play exercises often fail to explain why some pharmareps consistently meet and exceed management expectations while other equally knowledgeable reps do not.
Pharmaceutical representatives (pharmareps) are facing new challenges as a result of these transformations that have drastically altered the pharmaceutical sales landscape. Essential Competencies in Pharmaceutical Sales First, let’s review the competencies of a successful sales rep in pharma.
More consumers than ever are foregoing primary care physicians and annual check-ups in favor of occasional urgent care visits—and telehealth has great potential to be a convenient, centralized access point. Meanwhile, 90% of patients believe their primary care physician will give them solid information to help them and their disorder.
The virtual format enables diverse stakeholders, including patients, caregivers, patient advocates, physicians, nurses, pharmacists, and allied health providers, to share their unique perspectives without geographical, language, or time zone barriers. Some physicians still prefer to communicate via emails.
This engagement is continuing to remain high, with evolving requirements and preferences of healthcare practitioners (HCPs) in the ways they engage with pharmareps and medical science liaisons (MSLs) through virtual communications. Five steps to closing the CX gap with HCPs and Patients.
Finally, diving into the essentials of pursuing a career in electrophysiology med device sales, Keila highlights the need for a genuine curiosity to understand complex information and adaptability in this dynamic field. We had pharmareps come through. You have to have the interest and mindset to handle the complex information.
Let’s get into that space because that’s a space that there isn’t enough information about as a whole. Ophthalmology offices opened quicker than most doctors’ or physicians’ offices did. I would call on physicians during the day. I would say it’s equivalent probably to a pharmarep.
A series of studies and surveys have documented the fact that substantial numbers of physicians, nurses, and allied health professionals are active on or prefer social media for professional purposes and to connect directly with peers. A majority of HCPs want to receive relevant information on their own times and terms.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content